Published in Proc Soc Exp Biol Med on September 01, 1978
Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension. Cardiovasc Res (2007) 1.70
Development of secondary polycythaemia in chronic airways obstruction. Thorax (1981) 0.99
Development of pulmonary arterial hypertension in women: interplay of sex hormones and pulmonary vascular disease. Womens Health (Lond Engl) (2010) 0.92
Metabolic and hormonal derangements in pulmonary hypertension: from mouse to man. Int J Clin Pract Suppl (2010) 0.81
Pulmonary hypertension in women. Expert Rev Cardiovasc Ther (2010) 0.79
Diverse effects of stanozolol in C57BL/6J and A/J mouse strains. Eur J Appl Physiol (2008) 0.76
Sex differences in the tolerance of immature rat myocardium to global ischemia. Basic Res Cardiol (1989) 0.75
Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med (1993) 3.63
Mitochondrial DNA analysis in Tibet: implications for the origin of the Tibetan population and its adaptation to high altitude. Am J Phys Anthropol (1994) 3.40
End points in pulmonary arterial hypertension: the way forward. Eur Respir J (2004) 2.21
Arterial oxygen saturation in Tibetan and Han infants born in Lhasa, Tibet. N Engl J Med (1995) 2.13
Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension. Circulation (1982) 1.92
The effect of high altitude and other risk factors on birthweight: independent or interactive effects? Am J Public Health (1997) 1.85
Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs. Circ Res (1976) 1.76
Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol (1990) 1.74
Comments on "Moebius syndrome: animal model--human correlations and evidence for a brainstem vascular etiology". Teratology (1991) 1.73
The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J Clin Invest (1999) 1.71
Hypoxaemia and aortic chemoreceptor function in foetal lambs. J Physiol (1969) 1.68
Congenital pulmonary lymphangiectasis. Am J Dis Child (1970) 1.64
Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int (1998) 1.64
Altitude, low birth weight, and infant mortality in Colorado. JAMA (1988) 1.61
Operation Everest II: oxygen transport during exercise at extreme simulated altitude. J Appl Physiol (1985) (1988) 1.60
Nonimmunological production of leukotrienes induced by platelet-activating factor. Science (1982) 1.58
Operation Everest II: elevated high-altitude pulmonary resistance unresponsive to oxygen. J Appl Physiol (1985) (1987) 1.56
Effect of altitude on uterine artery blood flow during normal pregnancy. J Appl Physiol (1985) (1995) 1.55
Cyanide stimulation of the systemic arterial chemoreceptors in foetal lambs. J Physiol (1969) 1.55
Alterations in uteroplacental blood flow precede hypertension in preeclampsia at high altitude. J Appl Physiol (1985) (1995) 1.52
Y chromosome polymorphisms in native American and Siberian populations: identification of native American Y chromosome haplotypes. Hum Genet (1997) 1.52
Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest (1987) 1.50
Smaller alveolar-arterial O2 gradients in Tibetan than Han residents of Lhasa (3658 m). Respir Physiol (1996) 1.45
Internal carotid arterial flow velocity during exercise in Tibetan and Han residents of Lhasa (3,658 m). J Appl Physiol (1985) (1992) 1.43
High-altitude pulmonary edema in the children and young adults of Leadville, Colorado. N Engl J Med (1977) 1.43
Histamine H1- and H2-receptors in pulmonary and systemic vasculature of the dog. Am J Physiol (1975) 1.40
Severe pulmonary hypertension and arterial adventitial changes in newborn calves at 4,300 m. J Appl Physiol (1985) (1987) 1.40
Altered blood pressure course during normal pregnancy and increased preeclampsia at high altitude (3100 meters) in Colorado. Am J Obstet Gynecol (1999) 1.39
Role of endothelin-1 in lung disease. Respir Res (2001) 1.36
Quantitative estimation of human uterine artery blood flow and pelvic blood flow redistribution in pregnancy. Obstet Gynecol (1992) 1.36
Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension. Br J Pharmacol (2008) 1.35
Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2. J Clin Invest (1983) 1.33
Recombinant tumor necrosis factor/cachectin and interleukin 1 pretreatment decreases lung oxidized glutathione accumulation, lung injury, and mortality in rats exposed to hyperoxia. J Clin Invest (1987) 1.32
Endothelial cells in culture produce a vasoconstrictor substance. J Cell Physiol (1987) 1.31
The genetic factor influencing pulmonary hypertension in cattle at high altitude. Cardiovasc Res (1974) 1.30
Chronic obstructive bronchopulmonary disease. II. Oxygen transport in two clinical types. Am J Med (1968) 1.28
Minimal hypoxic pulmonary hypertension in normal Tibetans at 3,658 m. J Appl Physiol (1985) (1993) 1.26
Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. Am J Physiol (1997) 1.26
Oxygen-radical-mediated permeability edema and vasoconstriction in isolated perfused rabbit lungs. Am Rev Respir Dis (1982) 1.25
Operation Everest II: pulmonary gas exchange during a simulated ascent of Mt. Everest. J Appl Physiol (1985) (1987) 1.24
The case for treatment of selected patients with primary pulmonary hypertension. Am Rev Respir Dis (1986) 1.21
The oocyte and its role in regulating ovulation rate: a new paradigm in reproductive biology. Reproduction (2004) 1.19
Pre-excitation as a cause of appearance and increased intensity of systolic murmurs. Circulation (1966) 1.17
Sustained coronary vasoconstriction provoked by a peptidergic substance released from endothelial cells in culture. J Pharmacol Exp Ther (1986) 1.17
Altitude-aggravated illness: examples from pregnancy and prenatal life. Ann Emerg Med (1987) 1.16
Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension. Am J Cardiol (1978) 1.15
Relative contributions of endothelial, inducible, and neuronal NOS to tone in the murine pulmonary circulation. Am J Physiol (1999) 1.15
Failure of hypoxic pulmonary vasoconstriction in patients with liver cirrhosis. J Clin Invest (1972) 1.15
Nitric oxide production in the hypoxic lung. Am J Physiol Lung Cell Mol Physiol (2001) 1.15
Acclimatization to 4,300-m altitude decreases reliance on fat as a substrate. J Appl Physiol (1985) (1996) 1.14
Variable expression of endothelial NO synthase in three forms of rat pulmonary hypertension. Am J Physiol (1999) 1.14
Leukotriene C4 and D4 in neonates with hypoxemia and pulmonary hypertension. N Engl J Med (1983) 1.11
Hypoxic ventilatory responsiveness in Tibetan compared with Han residents of 3,658 m. J Appl Physiol (1985) (1993) 1.11
Acute hypoxia causes membrane depolarization and calcium influx in fetal pulmonary artery smooth muscle cells. Am J Physiol (1994) 1.11
Oxygen transport during steady-state submaximal exercise in chronic hypoxia. J Appl Physiol (1985) (1991) 1.10
Women at altitude: short-term exposure to hypoxia and/or alpha(1)-adrenergic blockade reduces insulin sensitivity. J Appl Physiol (1985) (2001) 1.10
Lung vascular smooth muscle as a determinant of pulmonary hypertension at high altitude. Am J Physiol (1975) 1.09
Increased dependence on blood glucose after acclimatization to 4,300 m. J Appl Physiol (1985) (1991) 1.09
Systemic hypertension at 4,300 m is related to sympathoadrenal activity. J Appl Physiol (1985) (1994) 1.08
Human llamas: adaptation to altitude in subjects with high hemoglobin oxygen affinity. J Clin Invest (1978) 1.08
Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension. Am J Physiol (1992) 1.08
Measurement of cardiac output by electrical impedance at rest and during exercise. J Appl Physiol (1976) 1.08
Muscle accounts for glucose disposal but not blood lactate appearance during exercise after acclimatization to 4,300 m. J Appl Physiol (1985) (1992) 1.08
Physiological effects of high altitude on the pulmonary circulation. Int Rev Physiol (1979) 1.07
Sympathetic and parasympathetic indicators of heart rate control at altitude studied by spectral analysis. J Appl Physiol (1985) (1994) 1.06
Alveolar inflammation and arachidonate metabolism in monocrotaline-induced pulmonary hypertension. Am J Physiol (1985) 1.06
Fluid retention and relative hypoventilation in acute mountain sickness. Respiration (1982) 1.06
Prevention and reversal of hypoxic pulmonary hypertension by calcium antagonists. Am Rev Respir Dis (1984) 1.06
Functional coronary microvascular injury evident as increased permeability due to brief ischemia and reperfusion. Circ Res (1990) 1.06
Upregulation of nitric oxide synthase in mice with severe hypoxia-induced pulmonary hypertension. Respir Res (2001) 1.06
Endotoxin and prevention of hypoxic pulmonary vasoconstriction. J Lab Clin Med (1976) 1.06
Selective expansion of fibroblast subpopulations from pulmonary artery adventitia in response to hypoxia. Am J Physiol Lung Cell Mol Physiol (2002) 1.05
Decreased reliance on lactate during exercise after acclimatization to 4,300 m. J Appl Physiol (1985) (1991) 1.05
Endothelin 1 causes pulmonary vasodilation in rats. Am J Physiol (1990) 1.05
Arterial catecholamine responses during exercise with acute and chronic high-altitude exposure. Am J Physiol (1991) 1.05
EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs. Am J Physiol (1993) 1.05
The incidence of pregnancy-induced hypertension is increased among Colorado residents at high altitude. Am J Obstet Gynecol (1982) 1.05
Acute mountain sickness in children at 2835 meters. Am J Dis Child (1993) 1.04
Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women. J Appl Physiol (1985) (1989) 1.04
Hypoxia increases glutathione redox cycle and protects rat lungs against oxidants. J Appl Physiol (1985) (1988) 1.04
Pulmonary vasodilation to endothelin isopeptides in vivo is mediated by potassium channel activation. J Appl Physiol (1985) (1991) 1.04
Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat. Am Rev Respir Dis (1992) 1.04
Endothelin-1 and endothelin-3 induce chemotaxis and replication of pulmonary artery fibroblasts. Am J Respir Cell Mol Biol (1992) 1.04
Operation Everest II: man at extreme altitude. J Appl Physiol (1985) (1987) 1.03
The mitogenic effects of the B beta chain of fibrinogen are mediated through cell surface calreticulin. J Biol Chem (1995) 1.03
Maturational changes in endothelium-derived relaxing factor activity of ovine pulmonary arteries in vitro. Am J Physiol (1991) 1.03
Comparative pharmacology of rat and porcine endothelin in rat aorta and pulmonary artery. Eur J Pharmacol (1989) 1.03
Greater maximal O2 uptakes and vital capacities in Tibetan than Han residents of Lhasa. Respir Physiol (1990) 1.02
Altitude and beta-blockade augment glucose utilization during submaximal exercise. J Appl Physiol (1985) (1996) 1.02
Successful replacement of a thrombosed mitral ball-valve prosthesis. JAMA (1965) 1.02
Combined effects of female hormones and metabolic rate on ventilatory drives in women. J Appl Physiol (1985) (1989) 1.02
Effects of hypoxia on endothelium-dependent relaxation of rat pulmonary artery. Am J Physiol (1990) 1.01
Acute hypoxia increases cytosolic calcium in fetal pulmonary artery smooth muscle cells. Am J Physiol (1993) 1.01
Lungs from chronically hypoxic rats have decreased pressor response to acute hypoxia. Am J Physiol (1978) 1.01